Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes

NCT07558525
unknownnot_applicable

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT06191328
unknownnot_applicable

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

NCT06007014

Clinical Trials (3)

Showing 3 of 3 trials
NCT07558525Not Applicable

Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes

Not Yet Recruiting
NCT06191328Not Applicable

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

Unknown
NCT06007014Not Applicable

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3